• Asahi Kasei Bioprocess will unveil the VANTIJ SU-VFC Benchtop, an automated single-use virus filtration system for lab-scale gene therapy manufacturing.
• Launch planned at Bioprocess International East 2026; on-site availability scheduled for Sept. 22-25 in Boston.
• Product expands the VANTIJ platform into benchtop format, targeting process development workflows using 0.12 m² or 0.3 m² Planova 35N filters.
• System design aims to standardize setup and execution through guided layouts, tool-free tube set changes, recipe-driven software, batch reporting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Asahi Kasei Corporation published the original content used to generate this news brief on September 15, 2026, and is solely responsible for the information contained therein.